BlackRock’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $146M | Sell |
|
|||||
|
2024
Q1 | $230M | Sell |
|
|||||
|
2023
Q4 | $256M | Buy |
|
|||||
|
2023
Q3 | $109M | Buy |
|
|||||
|
2023
Q2 | $154M | Buy |
|
|||||
|
2023
Q1 | $109M | Buy |
|
|||||
|
2022
Q4 | $141M | Buy |
|
|||||
|
2022
Q3 | $118M | Buy |
|
|||||
|
2022
Q2 | $109M | Buy |
|
|||||
|
2022
Q1 | $119M | Sell |
|
|||||
|
2021
Q4 | $113M | Buy |
|
|||||
|
2021
Q3 | $99.2M | Buy |
|
|||||
|
2021
Q2 | $68M | Buy |
|
|||||
|
2021
Q1 | $15.1M | Buy |
|
|||||
|
2020
Q4 | $18.2M | Buy |
|